SCHEMBL15538880

SCHEMBL15538880

O=C(O)c1ccc(-c2ccc(NCC3CCN(CC4(C(F)(F)F)CCC4)CC3)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SSTR5 P35346 2/20 0.47
LTA4H P09960 2/20 0.45
KDM1A O60341 5/20 0.40
WNT1 P04628 2/20 0.37
GSK3B P49841 2/20 0.37
DYRK1A Q13627 2/20 0.37
CHRM4 P08173 2/20 0.37
PIM1 P11309 1/20 0.37
DRD2 P14416 1/20 0.36
MAOB P27338 1/20 0.36
HTR2A P28223 1/20 0.36
SLC6A4 P31645 1/20 0.36
SCN5A Q14524 1/20 0.36
CARM1 Q86X55 1/20 0.36
PRMT6 Q96LA8 1/20 0.36
ACHE P22303 1/20 0.35
BACE1 P56817 1/20 0.35
CHRM2 P08172 1/20 0.35
CHRM1 P11229 1/20 0.35
FNTA P49354 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16777422 0.89 CHRM4 (0.43) SSTR5LTA4HKDM1AWNT1GSK3B
SCHEMBL16777159 0.86 HDAC4 (0.43) SSTR5
SCHEMBL15538532 0.86 HDAC4 (0.43) SSTR5
SCHEMBL21535004 0.86 GRM5 (0.46) SSTR5
SCHEMBL21535029 0.85 SSTR5 (0.35) SSTR5LTA4HWNT1GSK3BDYRK1A
SCHEMBL15539542 0.85 HRH3 (0.40) SSTR5
SCHEMBL15540101 0.85 HRH3 (0.40) SSTR5
SCHEMBL15538915 0.85 HRH3 (0.40) SSTR5
SCHEMBL20053632 0.84 PDK2 (0.43) SSTR5
SCHEMBL20053705 0.83 PDK2 (0.40) SSTR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2858986-B1 PIPERIDINE DERIVATIVES AS GPR119 AGONISTS CHONG KUN DANG PHARMACEUTICAL CORP (KR) 2019-10-30 EP disclosed
US-9944600-B2 Piperidine derivatives for GPR119 agonist CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2018-04-17 US disclosed
US-20150166480-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2015-06-18 US disclosed
EP-2858986-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST Chong Kun Dang Pharmaceutical Corp. (KR) 2015-04-15 EP disclosed
WO-2013187646-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2013-12-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166480-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST GPR119, FFAR2, GPR84 SSTR5 104/4885LTA4H 1459/4885KDM1A 1922/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.